|     home    |     search     |     content     |     mail     |     login     |
studies of Virologie (144) which were not included in the Bolder project

with reason for exclusion.

218511181-3-2002Both R5 and X4 human immunodeficiency virus type 1 variants persist during prolonged therapy with five antiretroviral drugs.
reason:
212687701-5-2001Timing of the Introduction into Ethiopia of Subcluster C' of HIV Type 1 Subtype C.
reason:
212255881-5-2001One-tube real-time isothermal amplification assay to identify and distinguish human immunodeficiency virus type 1 subtypes a, b, and c and circulating recombinant forms ae and ag.
reason:
2120119520-4-2001N-linked glycosylation of the HIV type-1 gp120 envelope glycoprotein as a major determinant of CCR5 and CXCR4 coreceptor utilization.
reason:
211792571-4-2001Single rapid real-time monitored isothermal rna amplification assay for quantification of human immunodeficiency virus type 1 isolates from groups m, n, and o.
reason:
211263971-3-2001Evolutionary relationships among parvoviruses: virus-host coevolution among autonomous primate parvoviruses and links between adeno-associated and avian parvoviruses.
reason:
2102652222-12-2000Slower decline of plasma HIV-1 RNA following highly suppressive antiretroviral therapy in primary compared with chronic infection.
reason:
205698021-12-2000Epidemiology of HIV-1 and emerging problems.
reason:
2100258020-11-2000Identification of a genetic subcluster of HIV type 1 subtype C (C') widespread in Ethiopia.
reason:
2055078810-11-2000Infection by zidovudine-resistant HIV-1 compromises the virological response to stavudine in a drug-naive patient.
reason:
205280571-11-2000Risk factors for hepatotoxicity in HIV-1-infected patients receiving ritonavir and saquinavir with or without stavudine.
reason:
2050731510-10-2000Evaluation of a second-generation nucleic acid sequence-based amplification assay for quantification of HIV type 1 RNA and the use of ultrasensitive protocol adaptations.
reason:
2047596520-9-2000Natural residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivo.
reason:
2033186710-6-2000Determinants for the syncytium-inducing phenotype of HIV-1 subtype F isolates are located in the V3 region.
reason:
2026546914-4-2000Reduction of the HIV-1-infected T-cell reservoir by immune activation treatment is dose-dependent and restricted by the potency of antiretroviral drugs.
reason:
200949481-2-2000Two distinct gamma-2 herpesviruses in African green monkeys: a second gamma-2 herpesvirus lineage among old world primates?
reason:
200949491-2-2000Papio cynocephalus endogenous retrovirus among old world monkeys: evidence for coevolution and ancient cross-species transmissions.
reason:only monkeys
200366221-12-1999Specific passage of simian immunodeficiency virus fromend-stage disease results in accelerated progression to AIDS in rhesus macaques.
reason:Geen cohort samples, dieren.
2004635420-11-1999Circulation of subtype A and gagA/envB recombinant HIV type 1 strains among injecting drug users in St. Petersburg, Russia, correlates with geographical origin of infections.
reason:Geen cohort samples, Rusland.
994123121-10-1999Discovery of a new endogenous type C retrovirus (FcEV) in cats: evidence for RD-114 being an FcEV(Gag-Pol)/baboon endogenous virus BaEV(Env) recombinant.
reason:Geen cohort samples, dieren.

displaying records 1 to 20 of 144


  • click on a studycode to view more details
  • click on "all studies" to view a list of all studies for this institute
  • click on "included studies" to view a list of all studies for this institute that were included in the Bolder project.
  • if not all records are displayed, click on 'display all records' to view them all
  • click on the back button to go to the previous screen